| Dr Matthew Hammond I, MD | |
|
1500 S Dobson Rd Ste 313, Mesa, AZ 85202-4752 | |
| (480) 561-6000 | |
| Not Available |
| Full Name | Dr Matthew Hammond I |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 24 Years |
| Location | 1500 S Dobson Rd Ste 313, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902829799 | NPI | - | NPPES |
| 296133 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 282830-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valleywise Health Medical Center | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carrot Eye Center, Pllc | 4981946654 | 2 |
| District Medical Group Inc | 7315086691 | 356 |
News Archive
Aeterna Zentaris Inc. today announced that it has reached agreement with the Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for Solorel® (AEZS-130, macimorelin) which will enable the Company to complete the ongoing registration study required to gain approval as a diagnostic test for Adult Growth Hormone Deficiency (AGHD).
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
A research consortium headed by Professor Hossam Haick of the Technion-Israel Institute of Technology is developing a product that, when coupled with a smartphone, will be able to screen the user's breath for early detection of life-threatening diseases.
In a paper to be published Nov. 22 in the online edition of the journal Science, a team of University of Wisconsin-Madison researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells.
› Verified 6 days ago
| Entity Name | District Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336472448 PECOS PAC ID: 7315086691 Enrollment ID: O20091125000583 |
News Archive
Aeterna Zentaris Inc. today announced that it has reached agreement with the Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for Solorel® (AEZS-130, macimorelin) which will enable the Company to complete the ongoing registration study required to gain approval as a diagnostic test for Adult Growth Hormone Deficiency (AGHD).
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
A research consortium headed by Professor Hossam Haick of the Technion-Israel Institute of Technology is developing a product that, when coupled with a smartphone, will be able to screen the user's breath for early detection of life-threatening diseases.
In a paper to be published Nov. 22 in the online edition of the journal Science, a team of University of Wisconsin-Madison researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells.
› Verified 6 days ago
| Entity Name | Carrot Eye Center, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437615010 PECOS PAC ID: 4981946654 Enrollment ID: O20190918003062 |
News Archive
Aeterna Zentaris Inc. today announced that it has reached agreement with the Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for Solorel® (AEZS-130, macimorelin) which will enable the Company to complete the ongoing registration study required to gain approval as a diagnostic test for Adult Growth Hormone Deficiency (AGHD).
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
A research consortium headed by Professor Hossam Haick of the Technion-Israel Institute of Technology is developing a product that, when coupled with a smartphone, will be able to screen the user's breath for early detection of life-threatening diseases.
In a paper to be published Nov. 22 in the online edition of the journal Science, a team of University of Wisconsin-Madison researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Hammond I, MD 220 S 63rd St, Mesa, AZ 85206-1619 Ph: (480) 641-3937 | Dr Matthew Hammond I, MD 1500 S Dobson Rd Ste 313, Mesa, AZ 85202-4752 Ph: (480) 561-6000 |
News Archive
Aeterna Zentaris Inc. today announced that it has reached agreement with the Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for Solorel® (AEZS-130, macimorelin) which will enable the Company to complete the ongoing registration study required to gain approval as a diagnostic test for Adult Growth Hormone Deficiency (AGHD).
Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.
A research consortium headed by Professor Hossam Haick of the Technion-Israel Institute of Technology is developing a product that, when coupled with a smartphone, will be able to screen the user's breath for early detection of life-threatening diseases.
In a paper to be published Nov. 22 in the online edition of the journal Science, a team of University of Wisconsin-Madison researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells.
› Verified 6 days ago
Dr. Neal A Nirenberg, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5620 E Broadway Rd, Mesa, AZ 85206 Phone: 480-981-6111 Fax: 480-985-2426 | |
Craig R Cassidy, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 W University, Suite 1, Mesa, AZ 85201 Phone: 480-833-0014 Fax: 480-835-6821 | |
Phillip David Boyer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 S Stapley Dr, Mesa, AZ 85204 Phone: 480-892-8400 Fax: 480-654-2868 | |
Michael A Pachtman, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1220 S Higley Rd Ste 106, Mesa, AZ 85206 Phone: 480-835-0709 Fax: 480-545-9321 | |
Dr. Warren E Hill, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5620 E Broadway Rd, Mesa, AZ 85206 Phone: 480-981-6111 Fax: 480-985-2426 | |
Dr. Yuri F Mckee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5620 E Broadway Rd, Mesa, AZ 85206 Phone: 480-981-6111 Fax: 480-985-2426 | |
Dr. Denise Dealva Garcia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1055 S Stapley Dr, Mesa, AZ 85204 Phone: 480-833-9100 |